首个！优于标准疗法，罗氏口服小分子3期积极结果公布罗氏（Roche）今日宣布，其3期evERA乳腺癌研究取得积极结果。数据显示，在既往接受过CDK4/6抑制剂及内分泌治疗的雌激素受体（ER）阳性、HER2阴性（HER2-）的局部晚期或转移性乳腺癌患者 ...
The Global Innovation Index 2025 report revealed that China leads globally in its number of innovation clusters, boasting 24 ...
The Global Innovation Index 2025 report revealed that China leads globally in its number of innovation clusters, boasting 24 that are ranked among the world's top 100. The Shenzhen-Hong Kong-Guangzhou ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈